174 related articles for article (PubMed ID: 7747277)
21. Direct measurement of aminopyrine N-demethylase and antipyrine hydroxylase activities in a monolayer rat primary isolated hepatocyte system.
Kotake AN
Biochem Pharmacol; 1981 Sep; 30(17):2473-9. PubMed ID: 21043248
[TBL] [Abstract][Full Text] [Related]
22. The effect of verapamil on antipyrine pharmacokinetics and metabolism in man.
Bach D; Blevins R; Kerner N; Rubenfire M; Edwards DJ
Br J Clin Pharmacol; 1986 Jun; 21(6):655-9. PubMed ID: 3741715
[TBL] [Abstract][Full Text] [Related]
23. The effect of malaria infection on antipyrine metabolite formation in the rat.
Mansor SM; Ward SA; Edwards G
Biochem Pharmacol; 1991 Apr; 41(8):1264-6. PubMed ID: 2009102
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effect of phenelzine on oxidative microsomal enzyme systems of rat liver.
Bélanger PM; Atitsé-Gbeassor A
Can J Physiol Pharmacol; 1983 May; 61(5):524-9. PubMed ID: 6883204
[TBL] [Abstract][Full Text] [Related]
25. Drug metabolism in liver disease: activity of hepatic microsomal metabolizing enzymes.
Farrell GC; Cooksley WG; Powell LW
Clin Pharmacol Ther; 1979 Oct; 26(4):483-92. PubMed ID: 487696
[TBL] [Abstract][Full Text] [Related]
26. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep.
Tufenkji AE; Alvinerie M; Pineau T; Boulard C; Galtier P
Xenobiotica; 1988 Apr; 18(4):357-64. PubMed ID: 3400265
[TBL] [Abstract][Full Text] [Related]
27. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
van den Broek JM; Teunissen MW; Breimer DD
Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
[TBL] [Abstract][Full Text] [Related]
28. Role of 3,4-dichlorophenyl methyl sulfone, a metabolite of o-dichlorobenzene, in the changes in hepatic microsomal drug-metabolizing enzymes caused by o-dichlorobenzene administration in rats.
Kato Y; Kimura R
Toxicol Appl Pharmacol; 1997 Aug; 145(2):277-84. PubMed ID: 9266800
[TBL] [Abstract][Full Text] [Related]
29. The effect of diltiazem on hepatic drug oxidation assessed by antipyrine and trimethadione.
Ohashi K; Sakamoto K; Sudo T; Tateishi T; Harada K; Fujimura A; Ebihara A; Tanaka E
J Clin Pharmacol; 1991 Dec; 31(12):1132-6. PubMed ID: 1761736
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of the effects of risedronate on hepatic microsomal drug metabolizing enzyme activities following administration to rats for 14 days: lack of an induction response.
Smith BJ; Hu JK; Schwecke WP
Drug Chem Toxicol; 1998 Aug; 21(3):291-303. PubMed ID: 9706462
[TBL] [Abstract][Full Text] [Related]
31. Hepatic microsomal drug metabolism, glutamyl transferase activity and in vivo antipyrine half-life in rats chronically fed an ethanol diet, a control diet and a chow diet.
Gadeholt G; Aarbakke J; Dybing E; Sjöblom M; Mørland J
J Pharmacol Exp Ther; 1980 Apr; 213(1):196-203. PubMed ID: 6102148
[TBL] [Abstract][Full Text] [Related]
32. Influence of cigarette smoke on antipyrine metabolite formation in rats.
Nakagawa A; Chiba K; Ishizaki T; Nakamura K
Res Commun Chem Pathol Pharmacol; 1983 Sep; 41(3):473-91. PubMed ID: 6635330
[TBL] [Abstract][Full Text] [Related]
33. Influence of amphotericin B treatment duration of hepatic microsomal enzyme function in rats.
Inselmann G; Voss V; Kunigk F; Heidemann H
Pharmacology; 1997 Aug; 55(2):87-94. PubMed ID: 9323308
[TBL] [Abstract][Full Text] [Related]
34. Induction potential of antifungals containing an imidazole or triazole moiety. Miconazole and ketoconazole, but not itraconazole are able to induce hepatic drug metabolizing enzymes of male rats at high doses.
Lavrijsen K; Van Houdt J; Thijs D; Meuldermans W; Heykants J
Biochem Pharmacol; 1986 Jun; 35(11):1867-78. PubMed ID: 3013201
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of 3-methylcholanthrene and phenobarbitone treatment on the oxidative metabolism of antipyrine in vitro by microsomal fractions of rat liver.
Kahn GC; Boobis AR; Murray S; Davies DS
Xenobiotica; 1982 Aug; 12(8):509-16. PubMed ID: 7147996
[TBL] [Abstract][Full Text] [Related]
36. The effect of velnacrine on the mixed function oxidase system.
Eccles MJ; Danbury TC; Ford JM; Roberts CJ
Eur J Drug Metab Pharmacokinet; 1997; 22(2):121-5. PubMed ID: 9248779
[TBL] [Abstract][Full Text] [Related]
37. [Effects of 18 alpha-glycyrrhizic acid on rat liver cytochrome P450 isoenzymes and phase II transferase].
Yang J; Peng RX; Kong R; Yu JP
Yao Xue Xue Bao; 2001 May; 36(5):321-4. PubMed ID: 12584850
[TBL] [Abstract][Full Text] [Related]
38. Lead intoxication: effects on cytochrome P-450-mediated hepatic oxidations.
Alvares AP; Fischbein A; Sassa S; Anderson KE; Kappas A
Clin Pharmacol Ther; 1976 Feb; 19(2):183-90. PubMed ID: 1261156
[TBL] [Abstract][Full Text] [Related]
39. The effect of age on antipyrine metabolism by liver microsomes isolated from phenobarbital-treated rats.
Henderson DJ; van Bezooijen CF
Mech Ageing Dev; 1989 Sep; 49(3):287-94. PubMed ID: 2811495
[TBL] [Abstract][Full Text] [Related]
40. The effect of indomethacin on hepatic drug-oxidizing capacity in the rat: trimethadione and antipyrine metabolism as an indicator.
Tanaka E; Kobayashi S; Aramphongphan A; Kurata N; Oguchi K; Kuroiwa Y; Yasuhara H
J Pharmacobiodyn; 1985 Sep; 8(9):773-9. PubMed ID: 4087137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
